Amelia M. Taylor
The University of Sydney(AU)Melanoma Institute Australia(AU)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Electrochemical sensors and biosensors, CAR-T cell therapy research, Organic Electronics and Photovoltaics
Most-Cited Works
- → PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer(2021)39 cited
- → Selectivity and potential interference from phenolic compounds in chemiluminescence methods for the determination of synephrine(2008)12 cited
- → BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes(2022)10 cited
- → Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy(2024)8 cited
- → Efficacy and safety of "second adjuvant" therapy with BRAF/MEK inhibitors after resection of recurrent melanoma following adjuvant PD-1–based immunotherapy.(2022)6 cited
- → Synthesis and polymerization studies of 3-(+) and (−)-menthyl carboxylate pyrroles(2007)6 cited
- → Metastatic primary breast neuroendocrine neoplasms: a case series(2022)4 cited
- → Nano-capsules of amphiphilic poly(ethylene glycol)-block-poly(bisphenol A carbonate) copolymers via thermodynamic entrapment(2016)1 cited
- → Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma(2024)1 cited
- → A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanoma(2025)